Trial Profile
Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-813160 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs BMS 813160 (Primary)
- Indications Hyperplasia
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 16 Jun 2014 New trial record